PMC:7652766 / 112057-112475
Annnotations
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T551 | 0-315 | Sentence | denotes | Despite the lack of studies in the literature showing the effect of these anthelmintics on the COVID-19 model, clinical trials have currently included this type of antiviral agent in many countries; there are 37 clinical trials using ivermectin alone or associated with hydroxychloroquine, and 19 with nitazoxanide. |
| T552 | 316-418 | Sentence | denotes | These studies are yet to be published and preliminary results are expected in the second half of 2020. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 4135 | 338-340 | Gene | denotes | to | Gene:6999 |
| 4136 | 234-244 | Chemical | denotes | ivermectin | MESH:D007559 |
| 4137 | 270-288 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 4138 | 302-314 | Chemical | denotes | nitazoxanide | MESH:C041747 |
| 4139 | 95-103 | Disease | denotes | COVID-19 | MESH:C000657245 |